Lilly Strattera Medicaid Reimbursement In 42 States; Launch Beats Lexapro
Executive Summary
Lilly's Strattera has gained Medicaid reimbursement in 42 states in the three months since the launch of the attention deficit disorder drug, Investor Relations Manager Craig Hartman told investors April 22